ArticleBlood advances2022

TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders.

Pietro Merli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.